Skip to Content
· Dermal Fillers
SKU 10971

Olidia 365

In stock
Volume
1 x 365 mg
Laboratory
PRP Life Science Co., Ltd.
Origin
South Korea
Indication
Severe facial wrinkles and folds, volume defects, facial lipoatrophy, facial contour deformities
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Olidia 365 - also known as Olidia 365MG or Olidia PLLA 365MG - is an injectable PLLA-based dermal filler from the OLIDIA brand (manufacturer PRP SCIENCE Co., Ltd., South Korea), designed for deep dermal use to support the correction of severe facial wrinkles and folds, replacement of volume defects, facial lipoatrophy, and improvement of facial contour deformities. Each vial contains 365 mg of dry powder - 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol - supplied as a single sterile vial and reconstituted with 5 mL of sterile water for injection prior to use, then injected into the lower dermis or hypodermis.

Key Benefits of Olidia 365

  • Improves severe facial wrinkles and folds
  • Replaces volume defects
  • Improves facial lipoatrophy
  • Improves facial contour deformities
  • PLLA-based formulation designed for a gradual tissue response after injection
Key Information
Brand OLIDIA
Manufacturer PRP SCIENCE Co., Ltd.
Country of Origin South Korea
Certification CE-marked (CE 1434)
Ingredients Per vial (365 mg dry powder): 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, 125 mg mannitol
Packaging 1 vial per box (365 mg dry powder), reconstituted with 5 mL of sterile water for injection prior to use
Use Type Professional / clinic use only - injectable PLLA collagen biostimulator for deep dermal/subcutaneous use
Injection Depth Subcutaneous layer / deep dermis
Protocol / Duration Generated collagen lasts for 2 years, after which the Olidia (PLLA) particles are biodegraded

Indications and Professional Use

Main indications

  • Severe facial wrinkles and folds
  • Volume defects
  • Facial lipoatrophy
  • Facial contour deformities

Professional use

Olidia 365 is intended strictly for professional use by qualified aesthetic practitioners, injected into the deep dermis / subcutaneous layer. For reconstitution, connect an 18G needle to the syringe and add 5 mL of sterile water for injection. For the injection itself, use a 26G sterile cannula or a 26G sterile needle, depending on the case-by-case treatment purpose.

Treatment areas

  • Face, including moderate to severe nasolabial folds.

Patient profile

Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Do not use in patients with malfunction of the liver or blood coagulation. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.

How Olidia 365 Works

Olidia 365 works through poly-L-lactic acid (PLLA) microparticles that stimulate a gradual tissue response after injection into the subcutaneous layer. This supports correction of severe facial wrinkles and folds, replacement of volume defects, improvement of facial lipoatrophy, and correction of facial contour deformities over time.

Why Order From Allpara

Allpara offers genuine, verified OLIDIA products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.

Frequently Asked Questions

Is Olidia 365MG suitable for facial lipoatrophy?

Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.

What is in the Olidia PLLA 365MG formula?

Each vial contains 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol.

How long do the results of Olidia 365 last?

Generated collagen lasts for about 2 years, after which the Olidia (PLLA) particles are biodegraded.

/ Specifications

The datasheet

Category
Dermal Fillers
Brand
OLIDIA
Laboratory
PRP Life Science Co., Ltd.
SKU
10971
Format
1 x 365 mg
Origin
South Korea
Indication
Severe facial wrinkles and folds, volume defects, facial lipoatrophy, facial contour deformities
Use
Professional injectable poly-L-lactic acid (PLLA) biostimulator, 365 mg per vial, subcutaneous layer / deep dermal
Treatment areas
/ Product details

The full file

Olidia 365 - also known as Olidia 365MG or Olidia PLLA 365MG - is an injectable PLLA-based dermal filler from the OLIDIA brand (manufacturer PRP SCIENCE Co., Ltd., South Korea), designed for deep dermal use to support the correction of severe facial wrinkles and folds, replacement of volume defects, facial lipoatrophy, and improvement of facial contour deformities. Each vial contains 365 mg of dry powder - 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol - supplied as a single sterile vial and reconstituted with 5 mL of sterile water for injection prior to use, then injected into the lower dermis or hypodermis.

PRP Life Science Co., Ltd., country of origin South Korea.

Shipped EU-wide from our EU warehouse, tracked and insured, with 24-72h dispatch. Each unit ships with batch number and expiry, held in EU bond and batch-traceable.

Store to manufacturer specification, away from direct light. Cold-chain is only used where the product requires it.

Net 30 / 60 / 90 day terms* are available to verified accounts on credit approval. Invoicing is supported in EUR, CHF and GBP.

Terms are indicative and confirmed after account review.

Is Olidia 365MG suitable for facial lipoatrophy?

Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.

What is in the Olidia PLLA 365MG formula?

Each vial contains 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol.

How long do the results of Olidia 365 last?

Generated collagen lasts for about 2 years, after which the Olidia (PLLA) particles are biodegraded.

/ Quick answers

Everything a buyer asks first

Is Olidia 365MG suitable for facial lipoatrophy?
Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.
What is in the Olidia PLLA 365MG formula?
Each vial contains 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol.
How long do the results of Olidia 365 last?
Generated collagen lasts for about 2 years, after which the Olidia (PLLA) particles are biodegraded.
/ FAQ

Frequently asked

Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.
Each vial contains 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol.
Generated collagen lasts for about 2 years, after which the Olidia (PLLA) particles are biodegraded.

More from PRP Life Science

View laboratory

Clinic alternatives

All products

Olidia 365

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Olidia 365 - also known as Olidia 365MG or Olidia PLLA 365MG - is an injectable PLLA-based dermal filler from the OLIDIA brand (manufacturer PRP SCIENCE Co., Ltd., South Korea), designed for deep dermal use to support the correction of severe facial wrinkles and folds, replacement of volume defects, facial lipoatrophy, and improvement of facial contour deformities. Each vial contains 365 mg of dry powder - 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol - supplied as a single sterile vial and reconstituted with 5 mL of sterile water for injection prior to use, then injected into the lower dermis or hypodermis.

Key Benefits of Olidia 365

  • Improves severe facial wrinkles and folds
  • Replaces volume defects
  • Improves facial lipoatrophy
  • Improves facial contour deformities
  • PLLA-based formulation designed for a gradual tissue response after injection
Key Information
Brand OLIDIA
Manufacturer PRP SCIENCE Co., Ltd.
Country of Origin South Korea
Certification CE-marked (CE 1434)
Ingredients Per vial (365 mg dry powder): 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, 125 mg mannitol
Packaging 1 vial per box (365 mg dry powder), reconstituted with 5 mL of sterile water for injection prior to use
Use Type Professional / clinic use only - injectable PLLA collagen biostimulator for deep dermal/subcutaneous use
Injection Depth Subcutaneous layer / deep dermis
Protocol / Duration Generated collagen lasts for 2 years, after which the Olidia (PLLA) particles are biodegraded

Indications and Professional Use

Main indications

  • Severe facial wrinkles and folds
  • Volume defects
  • Facial lipoatrophy
  • Facial contour deformities

Professional use

Olidia 365 is intended strictly for professional use by qualified aesthetic practitioners, injected into the deep dermis / subcutaneous layer. For reconstitution, connect an 18G needle to the syringe and add 5 mL of sterile water for injection. For the injection itself, use a 26G sterile cannula or a 26G sterile needle, depending on the case-by-case treatment purpose.

Treatment areas

  • Face, including moderate to severe nasolabial folds.

Patient profile

Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Do not use in patients with malfunction of the liver or blood coagulation. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.

How Olidia 365 Works

Olidia 365 works through poly-L-lactic acid (PLLA) microparticles that stimulate a gradual tissue response after injection into the subcutaneous layer. This supports correction of severe facial wrinkles and folds, replacement of volume defects, improvement of facial lipoatrophy, and correction of facial contour deformities over time.

Why Order From Allpara

Allpara offers genuine, verified OLIDIA products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.

Frequently Asked Questions

Is Olidia 365MG suitable for facial lipoatrophy?

Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.

What is in the Olidia PLLA 365MG formula?

Each vial contains 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol.

How long do the results of Olidia 365 last?

Generated collagen lasts for about 2 years, after which the Olidia (PLLA) particles are biodegraded.

More from PRP Life Science

View laboratory →

Olidia 365 - also known as Olidia 365MG or Olidia PLLA 365MG - is an injectable PLLA-based dermal filler from the OLIDIA brand (manufacturer PRP SCIENCE Co., Ltd., South Korea), designed for deep dermal use to support the correction of severe facial wrinkles and folds, replacement of volume defects, facial lipoatrophy, and improvement of facial contour deformities. Each vial contains 365 mg of dry powder - 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol - supplied as a single sterile vial and reconstituted with 5 mL of sterile water for injection prior to use, then injected into the lower dermis or hypodermis.

PRP Life Science Co., Ltd., country of origin South Korea.

Shipped EU-wide from our EU warehouse, 24-72h dispatch, tracked and insured. Each unit ships with batch number and expiry, held in EU bond and batch-traceable. Store to manufacturer specification.

Net 30 / 60 / 90 day terms* for verified accounts on credit approval. Invoicing in EUR, CHF and GBP.

Is Olidia 365MG suitable for facial lipoatrophy?

Yes. Olidia 365 is indicated for the treatment of severe facial wrinkles and folds, volume defects, facial lipoatrophy, and facial contour deformities.

What is in the Olidia PLLA 365MG formula?

Each vial contains 365 mg of dry powder: 150 mg poly-L-lactic acid (PLLA), 90 mg sodium carboxymethylcellulose, and 125 mg mannitol.

How long do the results of Olidia 365 last?

Generated collagen lasts for about 2 years, after which the Olidia (PLLA) particles are biodegraded.

* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.